Mobile

RISK OF NOCTURNAL HYPOGLYCEMIA AND CRITICAL ARRHYTHMIAS WITH SITAGLIPTIN VERSUS GLIMEPIRIDE IN PATIENTS WITH TYPE 2 DIABETES Risikovergleich nächtlicher Hypoglykämie und kritischer Arrhythmien ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-003792-34

RISK OF NOCTURNAL HYPOGLYCEMIA AND CRITICAL ARRHYTHMIAS WITH SITAGLIPTIN VERSUS GLIMEPIRIDE IN PATIENTS WITH TYPE 2 DIABETES Risikovergleich nächtlicher Hypoglykämie und kritischer Arrhythmien unter Einnahme von Sitagliptin gegenüber Glimepirid bei ungenügend kontrollierten Patienten mit Typ-2-Diabetes

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Hypoglycemic episodes (HE) and time spent below critical values are the primary objectives of this study. We will calculate overall episodes/time (5 days) and nocturnal episodes. Analysis will be performed as change between baseline and EOT by group and between group comparison at study end for CGMS and ECG results.

Critère d'inclusion

  • Patients with diabetes mellitus type 2 inadequately controlled on metformin monotherapy

Liens